Biotech

All Articles

' Medical intuitiveness' led FDA advisors to back Zevra's rare health condition med

.Zevra Rehabs' uncommon ailment medicine seems to become on the road to approval this autumn after g...

Pfizer takes $230M struck after axing fell short DMD gene treatment

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) genetics therapy failure has blown a $230 millio...

AC Immune views 'spots' possible in Alzheimer's medicine data

.After greater than 20 years of deal with neurodegenerative health conditions, Swiss biotech air con...

GSK loses ph. 2 HPV vaccination over lack of best-in-class prospective

.GSK has broken up a phase 2 individual papillomavirus (HPV) injection coming from its own pipe afte...

OS Treatments refiles $6M IPO to money HER2 drug, preclinical ADCs

.Operating system Therapies will detail on the NYSE American stock substitution today by means of a ...

ALX's waning CD47 reaction rate sends inventory spiraling down

.ALX Oncology's period 2 stomach cancer cells action rate has actually compromised. After seeing its...

Ionis centers eye illness coming from intendeds of Roche-partnered prospect after records disappoint

.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of desires, urgi...

Biogen's CEO said no dangerous sell 2023. He prepares to become bold

.While Biogen's pharma peers are actually searching for late-stage possessions along with little bit...

Instil refills pipeline in $2B biobucks cope with ImmunOnco

.Instil Bio has been a biotech seeking a pipeline after it ditched its own lead resources over the l...

Biogen ignores Denali Alzheimer's collab

.Biogen has handed back rights to a very early Alzheimer's condition course to Denali Therapies, lea...